Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

JJanux Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
J

Janux Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
    Sep 14, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
    Aug 6, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
    May 7, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development
    Apr 27, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014
    Apr 16, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment
    Apr 1, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
    Feb 26, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011
    Feb 17, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
    Jan 26, 2026Janux - Investor Relations Press Releases
  • Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors
    Jan 22, 2026Janux - Investor Relations Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions